中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
8期
7-10,24
,共5页
黄尚明%吴智鑫%何明丰%李旷怡%谭峰%李莹莹%雷俊娜
黃尚明%吳智鑫%何明豐%李曠怡%譚峰%李瑩瑩%雷俊娜
황상명%오지흠%하명봉%리광이%담봉%리형형%뢰준나
B型脑钠肽%急诊室%TOAST分型%心源性栓塞型脑卒中%脑卒中
B型腦鈉肽%急診室%TOAST分型%心源性栓塞型腦卒中%腦卒中
B형뇌납태%급진실%TOAST분형%심원성전새형뇌졸중%뇌졸중
B-type natriuretic peptide%Emergency room%TOAST typing%Cardioembolic stroke%Stroke
目的探讨急诊室使用B型脑钠肽(BNP)即时检测技术(POCT)对急性缺血性脑卒中患者进行TOAST分型的快速筛选价值。方法入选拟诊为急性缺血性脑卒中的患者,在急诊室进行BNP POCT。入院后进一步完善检查,由神经病学专家对急性缺血性脑卒中患者进行TOAST分型:大动脉粥样硬化型(LAA)、心源性栓塞型(CE)、小动脉闭塞型(SAO)、不明原因型(SUE)和其他明确病因型(SOE)。结果入选病例172例,男81例,女91例,年龄33~97岁,平均(71.2±11.7)岁。其中LAA型67例(38.95%), CE型45例(26.16%),SAO型42例(24.42%),SOE组和SUE组合计18例(10.47%)。CE组患者较其他亚型组年龄、冠心病发生率高,病情重,住院时间长,预后不良(P<0.01)。本次研究中,BNP的平均值为(114.12±90.78)pg/mL,中位数为69.60pg/mL,CE组的BNP水平最高(P<0.01);其他组间的BNP差异无统计学意义(P>0.05)。结论BNP POCT技术可辅助用于CE组与其他TOAST各亚型组的快速鉴别与筛选。但该技术仅作为辅助诊断,急诊医师需结合患者的一般情况、临床病史、体格检查、实验室和影像学检查等,不可盲目根据BNP的单一检查结果,轻易下最终诊断。
目的探討急診室使用B型腦鈉肽(BNP)即時檢測技術(POCT)對急性缺血性腦卒中患者進行TOAST分型的快速篩選價值。方法入選擬診為急性缺血性腦卒中的患者,在急診室進行BNP POCT。入院後進一步完善檢查,由神經病學專傢對急性缺血性腦卒中患者進行TOAST分型:大動脈粥樣硬化型(LAA)、心源性栓塞型(CE)、小動脈閉塞型(SAO)、不明原因型(SUE)和其他明確病因型(SOE)。結果入選病例172例,男81例,女91例,年齡33~97歲,平均(71.2±11.7)歲。其中LAA型67例(38.95%), CE型45例(26.16%),SAO型42例(24.42%),SOE組和SUE組閤計18例(10.47%)。CE組患者較其他亞型組年齡、冠心病髮生率高,病情重,住院時間長,預後不良(P<0.01)。本次研究中,BNP的平均值為(114.12±90.78)pg/mL,中位數為69.60pg/mL,CE組的BNP水平最高(P<0.01);其他組間的BNP差異無統計學意義(P>0.05)。結論BNP POCT技術可輔助用于CE組與其他TOAST各亞型組的快速鑒彆與篩選。但該技術僅作為輔助診斷,急診醫師需結閤患者的一般情況、臨床病史、體格檢查、實驗室和影像學檢查等,不可盲目根據BNP的單一檢查結果,輕易下最終診斷。
목적탐토급진실사용B형뇌납태(BNP)즉시검측기술(POCT)대급성결혈성뇌졸중환자진행TOAST분형적쾌속사선개치。방법입선의진위급성결혈성뇌졸중적환자,재급진실진행BNP POCT。입원후진일보완선검사,유신경병학전가대급성결혈성뇌졸중환자진행TOAST분형:대동맥죽양경화형(LAA)、심원성전새형(CE)、소동맥폐새형(SAO)、불명원인형(SUE)화기타명학병인형(SOE)。결과입선병례172례,남81례,녀91례,년령33~97세,평균(71.2±11.7)세。기중LAA형67례(38.95%), CE형45례(26.16%),SAO형42례(24.42%),SOE조화SUE조합계18례(10.47%)。CE조환자교기타아형조년령、관심병발생솔고,병정중,주원시간장,예후불량(P<0.01)。본차연구중,BNP적평균치위(114.12±90.78)pg/mL,중위수위69.60pg/mL,CE조적BNP수평최고(P<0.01);기타조간적BNP차이무통계학의의(P>0.05)。결론BNP POCT기술가보조용우CE조여기타TOAST각아형조적쾌속감별여사선。단해기술부작위보조진단,급진의사수결합환자적일반정황、림상병사、체격검사、실험실화영상학검사등,불가맹목근거BNP적단일검사결과,경역하최종진단。
Objective To explore the value of rapid screening value of Point of Care Test(POCT) of B-type natriuretic peptide (BNP) for the TOAST typing in patients with acute ischemic stroke inemergency room. Methods Patients diagnosed as acute ischemic stroke were selected to carry POCT of BNP in the emergency room. And the further examinations were performed after admission, and then the patients with acute ischemic stroke were classified with TOAST by neurologists: large artery atherosclerosis (LAA), cardioembolism (CE), small artery occlusion (SAO), stroke of unknown cause type (SUE) and stoke of other determined cause (SOE). Results 172 patients included 81 men and 91 women who aged from 33 to 97 years old, mean age was (71.2±11.7) years old were selected. Among them there were 67 cases of LAA type (38.95%), 45 cases of CE type (26.16%), SAO type of 42 cases (24.42%), SOE type and SUE type total of 18 cases (10.47%). Compared with other groups, patients in the CE group were elder, had a higher incidence of coronary heart disease, more serious illness, longer duration of hospitalization and poorer prognosis (P<0.01). In this study, the average value of BNP was (114.12±90.78)pg/mL, and median of that was 69.60pg/mL. However, BNP level of patients with CE was the highest (P<0.01); there was no significant difference of BNP among other groups (P > 0.05). Conclusion POCT of BNP can be used for rapid identification and screening of the CE type from the other TOAST subtypes of ischemic stroke. However, emergency physicians should give diagnosis combining with the general situation of the patients, the clinical history, physical examination, laboratory and imaging examination, taken POCT only as a auxiliary diagnosis, can not easily get the final diagnosis blindly according to the test results of single BNP.